Diets are important to individuals’ health, with what a person consumes influencing their body by either strengthening their immune system or increasing their risk of developing lifestyle diseases. New research has found that diets high in fat may increase an individual’s sensitivity to nonpainful stimuli, causing chronic pain.
It is normally recommended for individuals to consume fat in order to ensure that their bodies function optimally. The Dietary Guidelines for Americans 2020–2025, recommend that less than 10% of calorie intake should come from saturated fats.
Worth noting is the fact that consuming a lot of fat may cause various issues. For instance, it may heighten an individual’s susceptibility to heart disease. This is why experts recommend that individuals consume healthier foods. Despite this, most people still follow diet trends that are high in fat and consume high levels of saturated fat, particularly in developed nations.
Previous studies have determined that diets high in fat could raise pain sensitivity. For their study, the researchers were mainly focused on determining whether these diets could trigger pain responses in cases where no obesity or diabetes was involved.
They used mice models for their study, which involved feeding the mice different diets. Over a period of eight weeks, some mice were fed a diet high in fat while others were given the standard chow diet.
The researchers observed that during this period, the mice that fed on a lot of fat didn’t develop hyperglycemia or obesity. However, these mice did have more elevated mechanical allodynia responses, which entails experiencing pain due to stimuli that isn’t painful.
Michael Burton, the study author, stated that the research had shown that pain could be triggered in the absence of diabetes, obesity or even injury.
Burton, who is a cellular & molecular neuroscience assistant professor at the University of Texas (Dallas), then noted that one could eat a diet high in fat but only for a limited duration of time.
The primary limitation of the research was its use of mice models, which limited the amount of data that could be applied to people. As investigators learn more about the possibly harmful effects of eating patterns involving foods that are high in fat, individuals who follow these diets are advised to exercise caution.
If you would like to develop a diet plan that best suits your needs, it is recommended that you work with nutrition experts and healthcare professionals, particularly if you’re on medication or suffer from a chronic illness.
For patients grappling with chronic pain, help may be on the horizon because several for-profit entities such as India Globalization Capital Inc. (NYSE American: IGC) are investing significant resources into developing cannabis-based treatments for this indication as an alternative to the existing pharmaceuticals.
NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://ibn.fm/IGC
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.